March 24, 2009

The present invention relates to novel pharmaceutical compositions based on fluorene carboxylic acid ester derived anticholinergics of formula 1 ##STR00001## and soluble TNF receptor fusion proteins, processes for preparing them and their use in the treatment of respiratory diseases.

18

March 24, 2009

11/038,658

January 18, 2005

514/291   424/45 424/46 424/489 514/2 514/304 546/128 546/91

A01N   43/42   (20060101)   A01N   43/46   (20060101)   A61K   38/01   (20060101)   A61K   9/08   (20060101)   A61K   9/10   (20060101)   A61K   9/12   (20060101)   A61K   9/14   (20060101)   A61K   9/48   (20060101)   C07D   451/00   (20060101)   C07D   451/04   (20060101)  

RELATED APPLICATIONS Benefit of U.S. Provisional Application Ser. No. 60/559,855, filed on Apr. 6, 2004, and EP 04003896, filed on Feb. 20, 2004 is hereby claimed, which applications are incorporated herein in their entirety.

Feb 20, 2004 [EP] 04003896

514/2   514/291   514/304   546/89   546/91   546/128